Immune Checkpoint Blockade Improves Chemotherapy in the PyMT Mammary Carcinoma Mouse Model

Despite the success of immune checkpoint blockade in cancer, the number of patients that benefit from this revolutionary treatment option remains low. Therefore, efforts are being undertaken to sensitize tumors for immune checkpoint blockade, which includes combining immune checkpoint blocking agent...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Sirait-Fischer, Evelyn, Olesch, Catherine, Fink, Annika F., Berkefeld, Matthias, Huard, Arnaud, Schmid, Tobias, Takeda, Kazuhiko, Brüne, Bernhard, Weigert, Andreas
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7513675/
https://ncbi.nlm.nih.gov/pubmed/33014872
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01771
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados